This topic contains a solution. Click here to go to the answer

Author Question: The nurse should stop the infusion of terbutaline (Brethine) in a client being treated for premature ... (Read 116 times)

Ebrown

  • Hero Member
  • *****
  • Posts: 567
The nurse should stop the infusion of terbutaline (Brethine) in a client being treated for premature uterine contractions based on which assessment findings?
 
  Standard Text: Select all that apply.
  1. Heart rate 110
  2. Premature ventricular contractions on electrocardiogram tracing
  3. Serum potassium level 3.0 mg/dL
  4. Cough and shortness of breath
  5. Reduction in uterine contractions

Question 2

The nurse should question the use of medroxyprogesterone acetate (Provera) in a client who:
 
  1. was hospitalized for depression 3 months ago.
  2. has just been diagnosed with anemia.
  3. was treated for acute bronchitis 2 weeks ago.
  4. had a cyst removed from her kidney 6 months ago.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

annierak

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Correct Answer: 1,2,3,4
Rationale 1: A serious adverse reaction to this medication is increased heart rate.
Rationale 2: Dysrhythmias are a serious adverse reaction to this medication.
Rationale 3: Hypokalemia is a serious adverse reaction to this medication.
Rationale 4: Pulmonary edema is a serious adverse reaction to this medication.
Rationale 5: Reduced uterine contractions are an expected effect of this medication.
Global Rationale: A serious adverse reaction to this medication is increased heart rate. Dysrhythmias are a serious adverse reaction to this medication. Hypokalemia is a serious adverse reaction to this medication. Pulmonary edema is a serious adverse reaction to this medication. Reduced uterine contractions are an expected effect of this medication.

Answer to Question 2

Correct Answer: 1
Rationale 1: Medroxyprogesterone should be used with caution in clients who have a history of depression; it should be discontinued at the first sign of depression.
Rationale 2: Anemia is not a contraindication to the use of medroxyprogesterone .
Rationale 3: Medroxyprogesterone is not contraindicated in clients with recent infections.
Rationale 4: Medroxyprogesterone is not contraindicated in a client who has had kidney surgery.
Global Rationale: Medroxyprogesterone should be used with caution in clients who have a history of depression; it should be discontinued at the first sign of depression. Anemia, recent infections, and kidney surgery are not contraindications to the use of medroxyprogesterone .




Ebrown

  • Member
  • Posts: 567
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


bigcheese9

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

For a complete list of videos, visit our video library